v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ (1,493,450) $ 196,712
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 47,215 42,019
Provision to write down inventories to net realizable value 638,966 20,674
Loss on impairment and disposal of property, plant and equipment 206,620  
Stock-based compensation expenses 112,818 115,015
Impairment of goodwill and intangible assets 24,725 0
Deferred income taxes, net 79,831 (18,199)
Gain from repurchasing of convertible notes (15,455) 0
Loss (gain) from exchange rate fluctuations 8,243 (8,170)
Other items 10,299 6,915
Changes in assets and liabilities:    
Trade receivables, net 379,214 (40,011)
Inventories, net 15,858 (458,475)
Prepaid expenses and other assets (38,223) 19,822
Operating lease right-of-use assets, net 12,286 12,323
Trade payables, net (284,255) (53,996)
Warranty obligations (39,294) 130,863
Deferred revenues and customers advances 1,253 18,580
Operating lease liabilities (11,881) (11,945)
Accrued expenses and other liabilities, net 19,574 (12,330)
Net cash used in operating activities (325,656) (40,203)
Cash flows from investing activities:    
Investment in available-for-sale marketable securities (200,919) (214,516)
Proceeds from maturities of available-for-sale marketable securities 632,866 191,810
Proceeds from sales of available-for-sale marketable securities 70,642 2,807
Purchase of property, plant and equipment (95,905) (130,024)
Business combinations, net of cash acquired (10,417) (16,653)
Purchase of intangible assets (10,000) (10,600)
Disbursements for loans receivables (37,500) (13,000)
Investment in privately-held companies (25,742) (8,000)
Other investing activities (4,270) 9,989
Net cash provided by (used in) investing activities 318,755 (188,187)
Cash flows from financing activities:    
Repurchase of common stock (50,315) 0
Partial repurchase of Notes 2025 (267,900) 0
Proceeds from issuance of Notes 2029, net of issuance costs 329,214 0
Capped call transactions related to Notes 2029 (28,342) 0
Tax withholding in connection with stock-based awards, net (592) (9,267)
Other financing activities (1,938) (2,038)
Net cash used in financing activities (19,873) (11,305)
Effect of exchange rate differences on cash and cash equivalents (7,790) 7,705
Decrease in cash and cash equivalents (34,564) (231,990)
Cash and cash equivalents at the beginning of the period 338,468 783,112
Cash and cash equivalents at the end of the period 303,904 551,122
Supplemental disclosure of non-cash activities:    
Purchase of intangible assets and business combinations 0 11,307
Right-of-use asset recognized with a corresponding lease liability 2,138 17,658
Purchase of property, plant and equipment $ 4,761 $ 19,574